KIMSNSEKrishna Institute of Medical Sciences Limited· Healthcare ServicesHighNeutral
Announced Tue, 23 Jun, 2026 · 14:01 IST

Listing approval for 1.98 crore QIP shares of Rs 2 each

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹807.85
prior close
₹803.75
announcement price
In-mkt
timing
Nifty Smallcap 250market-0.6%+0.3% vs market
Hospital peers, median of 22sector-0.5%+0.2% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.1
15m
+0.3
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3-0.6+0.3-0.5+0.2
Next day
-1.6-0.4-1.2-0.3-1.3
2d
-1.7-0.8-0.9-1.1-0.7
3d
-0.2-1.3+1.1-0.5+0.3
4d
+1.3-0.7+2.0+0.5+0.7
5d
+3.1-0.3+3.4+0.2+2.9
1w
+5.2+0.8+4.4+1.0+4.2
15d
+0.0+1.4-1.3+2.0-2.0
1m
-3.0-1.1-1.9-0.7-2.4
2m
-5.1+2.9-8.1-0.7-4.4
3m
-1.0+3.1-4.1-0.3-0.7
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Krishna Institute of Medical Sciences received approval for listing of 1,98,67,549 equity shares of Rs 2 face value issued to qualified institutional buyers through a Qualified Institutional Placement. The QIP route allows listed companies to raise capital from institutions without a follow-on public offer. These new shares will now be tradable on the stock exchanges, expanding the total share count.

Likely market impact

New shares add to the float, leading to dilution of existing holdings. Short-term supply pressure possible, though QIP indicates institutional confidence in the company.